SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alan M. Solinger who wrote (1065)6/17/1998 11:02:00 AM
From: luis a. garcia  Read Replies (2) of 1115
 
And we think that is a very uninformed stand. That is why we are taking the time to enlighten you. Katz is a troubled man. However there are very good people there performing very well. They will have this major drug to their credit and it will be the first of many under
dc Yakatan's directrion. They are looking to fill their pipeline not necessarily from MBI stuff since that is longer ways away. They want to have a second drug in three years time..etc..Lidakol revenues will be expected to push eps upwards of a dollar to a dollar fifty..
40% ABORTED EPISODES
50% REDUCTION TIME TO HEALING AN EPISODE
54 HOURS TO CESSATION OF PAIN AND DISCONFORT
BETTER THAN ACYCLOVIR AND PENCYCLOVIR
SAFER SAFER SAFER... NOT AN ANALOG NUCLEOSIDE... NON MUTAGENIC...SHOE IN FOR OVER THE COUNTER DISTRIBUTION, CHEAP TO MANUFACTURE, FAT MARGINS....
regards
luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext